SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
772Give us a puking break. BCRX has an outstanding program in PNP inhibitors. It&scaram(o)uche-12/30/2005
771<i>any biotech stock and any company that could potentially announce a newtom pope-12/30/2005
770We all agree I guess: - BCRX IS a risky short - the risk of bad avian flu news enrico99-12/30/2005
769Yes, but Peter, is that bad avian flu news at all likely to erupt this year? (Wtom pope-12/29/2005
768Playing with fire here in my opinion. If there is bad Avian flu news then BCRX wBiomaven-12/29/2005
767I myself shorted the other day at $17.40. I also went short the March $20 callsI_Banker-12/29/2005
766I_Banker, I'm short a thousand shares. My bet is I will break 10 $ a shaenrico99-12/29/2005
765Anybody look at shorting BCRX after the pop on FDA approval to begin Phase I/II I_Banker-12/29/2005
764SEPR short would have worked better. The SGP rumor seems to be fading and the gRobohogs-11/29/2005
763FWIW, I sold my puts in NBIX on the drop to 60. I may keep trading this one, patuck-11/28/2005
762I note a pretty good dose of insider selling at NBIX the last few days. Makes mtuck-11/28/2005
761Quid, I agree with your reasoning. If PFE is going to make any rash moves, it Robohogs-11/27/2005
760tuck, regarding NBIX and a buyout being baked in and supporting pps, I agree witquidditch-11/27/2005
759On OSCI, I am concerned that there is no ramp in the world in that gets the drugRobohogs-11/24/2005
758shorting styles... As an opening statement, I realize that going short stocks tformer_pgs-11/24/2005
757Answering all these recent posts at once . . . CELG is among those mentiotuck-11/24/2005
756I think the following biotechs are worthwhile shorts for the long haul (imo): Nformer_pgs-11/23/2005
755I agree that we should be looking for more shorts amoung the biotechs. But we sIRWIN JAMES FRANKEL-11/23/2005
754CELG? Seems way overdone and an approvable would hit stock hard. Jon PS NBIXRobohogs-11/23/2005
753Trimeris eventually went under $13 as it should have, but popped back up again, tuck-11/23/2005
752Sold at $14.95, bought at $14.40, could be worse. But stinky weird, I agree. Ituck-10/21/2005
751So, basically, you call everything dead right and the stock acts inversely. Stikeokalani'nui-10/21/2005
750I redid my short of TRMS yesterday at $14.95. TRMS almost hit the GS number, sotuck-10/20/2005
749>>MORRISVILLE, N.C.--(BUSINESS WIRE)--Oct. 18, 2005--Trimeris, Inc. (NASDAtuck-10/18/2005
748Thanks to Steve (quidditch) for this dig from Goldman Sachs regarding Trimeris: tuck-10/6/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):